HARTLINE INVESTMENT CORP/
Position in PACB — Pacific Biosciences Of California, Inc.
CIK 945625
WINNETKA, IL
Position in PACB
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$115,920
+$24,840 QoQ
Shares Held
69,000
0.0% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#87
of 221 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PACB Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026HARTLINE INVESTMENT CORP/ holds $9,407,250 across 6 Medical Devices names. PACB ranks #6 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GEHC |
GE HealthCare Technologies Inc.
|
92,747 | $5,936,735 | |
| 2 | SYK |
Stryker Corp
|
6,138 | $1,932,487 | |
| 3 | ABT |
Abbott Laboratories
|
8,123 | $737,081 | |
| 4 | MDT |
Medtronic plc
|
7,225 | $565,211 | |
| 5 | BFLY |
Butterfly Network, Inc.
|
14,230 | $119,816 | |
| 6 | PACB |
Pacific Biosciences Of California, Inc.
This page
|
69,000 | $115,920 |
All Filings in PACB
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $115,920 | 69,000 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $91,080 | 69,000 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $57,970 | 31,000 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $39,680 | 31,000 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $38,440 | 31,000 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $36,580 | 31,000 | Shares | Sole | 2025-04-29 | |
| No filing history on record for this holder in this stock. | ||||||